A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD

NCT05643638 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Graft Versus Host Disease, Acute

Interventions

BIOLOGICAL: CYP-001: Cymerus induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSCs)
BIOLOGICAL: Placebo
DRUG: Corticosteroids

Sponsor

Cynata Therapeutics Limited